Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Prince Pharmaceutical CoROCO:6935 -4.79%60 Days Inventory is 74.12 as of Dec. 2025, which is 25% below its 10-year median of 99.15. GuruFocus rates ROCO:6935 with a GF Score™ of 60/100 and a GF Value™ of NT$42.14 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 923 Drug Manufacturers companies, Prince Pharmaceutical Co ranks better than 87.87% on this metric.
The historical rank and industry rank for Prince Pharmaceutical Co's Days Inventory or its related term are showing as below:
ROCO:6935'
s Days Inventory Range Over the Past 10 Years
Min: 75.89 Med: 99.15 Max: 158.51
Current: 75.89
During the past 7 years, Prince Pharmaceutical Co's highest Days Inventory was 158.51. The lowest was 75.89. And the median was 99.15.
ROCO:6935's Days Inventory is ranked better than 87.87% of 923
companies
in the Drug Manufacturers industry
Industry Median: 164.38
vs ROCO:6935: 75.89
Inventory Turnover measures how fast the company turns over its inventory within a year.
Prince Pharmaceutical Co's Inventory Turnover for the
six
months ended in Dec. 2025 was 2.46.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Prince Pharmaceutical Co's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.31.
Prince Pharmaceutical Co (ROCO:6935) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Prince Pharmaceutical Co's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Prince Pharmaceutical Co's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Prince Pharmaceutical Co Days Inventory Related Terms
Prince Pharmaceutical Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Prince Pharmaceutical Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prince Pharmaceutical Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Prince Pharmaceutical Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Prince Pharmaceutical Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prince Pharmaceutical Co (ROCO:6935) has a Days Inventory of 74.12 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Prince Pharmaceutical Co and its competitors. This is 25% below median its historical median of 99.15. Over the past decade, Prince Pharmaceutical Co's Days Inventory has ranged from 75.89 to 158.51. According to the industry distribution chart, Prince Pharmaceutical Co ranks #112 out of 923 companies in the Drug Manufacturers industry, placing it in the top 12.1%.
Is Prince Pharmaceutical Co's Days Inventory too high?
Prince Pharmaceutical Co's current Days Inventory of 74.12 is 25% below median its 10-year median of 99.15. Over the past 10 years, this metric has ranged from a low of 75.89 to a high of 158.51. The Drug Manufacturers industry median Days Inventory is 164.38. Prince Pharmaceutical Co's value of 74.12 is 54.9% below this industry median. Based on the distribution chart, Prince Pharmaceutical Co ranks #112 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Prince Pharmaceutical Co has a GF Score™ of 60/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Prince Pharmaceutical Co's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Prince Pharmaceutical Co ranks #112 out of 923 companies for Days Inventory. This places Prince Pharmaceutical Co in the top 12% of its industry — outperforming the majority of peers. The industry median Days Inventory is 164.38. Prince Pharmaceutical Co's value of 74.12 is 54.9% below this benchmark. Historically, Prince Pharmaceutical Co's own Days Inventory has ranged from 75.89 to 158.51 over the past decade. While the company's 10-year median is 99.15 vs. the industry median of 164.38, Prince Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.38, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Prince Pharmaceutical Co's current Days Inventory of 74.12 is 54.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Prince Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Prince Pharmaceutical Co's current Days Inventory is 74.12, which is 25% below median its own 10-year median of 99.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Prince Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Prince Pharmaceutical Co (ROCO:6935) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$42.14, compared to a current price of NT$28.85 — trading 31.5% below its estimated fair value. The current Days Inventory is 74.12, which is 25% below median its 10-year median of 99.15 and 54.9% below the Drug Manufacturers industry median of 164.38. Prince Pharmaceutical Co's overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Prince Pharmaceutical Co (ROCO:6935), the current Days Inventory is 74.12 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Prince Pharmaceutical Co (ROCO:6935) Overvalued in 2026?
Based on GuruFocus' analysis, Prince Pharmaceutical Co stock appears to be undervalued.
The current stock price of NT$28.85 is trading 31.5% below its estimated GF Value™ of NT$42.14.
GuruFocus considers Prince Pharmaceutical Co to be Significantly Undervalued.
Key valuation signals for ROCO:6935:
Days Inventory: 74.12 (25% below median its 10-year median of 99.15)
GF Value™: NT$42.14 vs. price of NT$28.85 (31.5% below fair value)
Industry Position: 54.9% below the Drug Manufacturers median (#112 of 923)
No single metric tells the full story. See the ROCO:6935 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Prince Pharmaceutical Co Ltd is engaged in the manufacturing, packaging, processing, and trading of various active pharmaceutical ingredients and health supplements. The company supplies its products to Taiwan, Japan, Spain, Europe and other regions.
60GF Score
Get the complete analysis for ROCO:6935
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6935 has been successfully added to your 
